Zobrazeno 1 - 10
of 127
pro vyhledávání: '"Valentin, Goede"'
Autor:
Florian Simon, Rudy Ligtvoet, Thomas Noesslinger, Jan-Paul Bohn, Julia Von Tresckow, Rüdiger Liersch, Tobias Gaska, Kathleen Jentsch-Ullrich, Michael Koenigsmann, Thomas Wolff, Ingo Schwaner, Dominik Wolf, Christof Schneider, Eugen Tausch, Stephan Stilgenbauer, Karl-Anton Kreuzer, Sandra Robrecht, Anna-Maria Fink, Moritz Fürstenau, Kirsten Fischer, Valentin Goede, Michael Hallek, Barbara Eichhorst
Publikováno v:
HemaSphere, Vol 7, p e3844763 (2023)
Externí odkaz:
https://doaj.org/article/8a43f0f54e4c40a8b2e60240c8a0ce55
Autor:
Valentin Goede
Publikováno v:
Clinical Interventions in Aging. 18:505-521
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::52e7b6ad3ce2f3631261cfb8d38b9fdf
https://doi.org/10.2147/cia.s365494
https://doi.org/10.2147/cia.s365494
Autor:
Jennifer Edelmann, Karlheinz Holzmann, Eugen Tausch, Emily A. Saunderson, Billy M. C. Jebaraj, Daniela Steinbrecher, Anna Dolnik, Tamara J. Blätte, Dan A. Landau, Jenny Saub, Sven Estenfelder, Stefan Ibach, Florence Cymbalista, Veronique Leblond, Alain Delmer, Jasmin Bahlo, Sandra Robrecht, Kirsten Fischer, Valentin Goede, Lars Bullinger, Catherine J. Wu, Daniel Mertens, Gabriella Ficz, John G. Gribben, Michael Hallek, Hartmut Döhner, Stephan Stilgenbauer
Publikováno v:
Haematologica, Vol 105, Iss 5 (2020)
To identify genomic alterations contributing to the pathogenesis of high-risk chronic lymphocytic leukemia (CLL) beyond the well-established role of TP53 aberrations, we comprehensively analyzed 75 relapsed/refractory and 71 treatment-naïve high-ris
Externí odkaz:
https://doaj.org/article/b6616ac47caa446b810bf72999b7a258
Autor:
Monika Engelhardt, Gabriele Ihorst, Jesus Duque-Afonso, Ulrich Wedding, Ernst Spät-Schwalbe, Valentin Goede, Gerald Kolb, Reinhard Stauder, Ralph Wäsch
Publikováno v:
Haematologica, Vol 105, Iss 5 (2020)
Externí odkaz:
https://doaj.org/article/01f590cefcd543b4ba9ab3726dd8f645
Autor:
Sonia Jaramillo, Andreas Agathangelidis, Christof Schneider, Jasmin Bahlo, Sandra Robrecht, Eugen Tausch, Johannes Bloehdorn, Manuela Hoechstetter, Kirsten Fischer, Barbara Eichhorst, Valentin Goede, Michael Hallek, Hartmut Döhner, Richard Rosenquist, Paolo Ghia, Kostas Stamatopoulos, Stephan Stilgenbauer
Publikováno v:
Haematologica, Vol 105, Iss 11 (2019)
Almost one-third of all patients with chronic lymphocytic leukemia (CLL) express stereotyped B cell receptor immunoglobulins (BcR IG) and can be assigned to distinct subsets, each with a particular BcR IG. The largest stereotyped subsets are #1, #2,
Externí odkaz:
https://doaj.org/article/2602fd12de89436fbd5d86db1f2f2478
Autor:
Günter Fingerle-Rowson, Tina Nielsen, Jeffrey M. Venstrom, Christian Klein, Andres Cardona, Christopher R. Bolen, Nathalie Spielewoy, Deniz Sahin, Andrea Knapp, Harald Zeuner, Valentin Goede, Alexandra Bazeos, Umberto Vitolo, Laurie H. Sehn, Robert Marcus, Wolfgang Hiddemann, Marek Trněný, Mikkel Z. Oestergaard, Magdalena Klanova
Risk or severity of IRRs by NKCC (A) and by NKCC and treatment arm (B) in FL and DLBCL.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3266c267aa95fd5496ebd18124089fe4
https://doi.org/10.1158/1078-0432.22472261.v1
https://doi.org/10.1158/1078-0432.22472261.v1
Autor:
Günter Fingerle-Rowson, Tina Nielsen, Jeffrey M. Venstrom, Christian Klein, Andres Cardona, Christopher R. Bolen, Nathalie Spielewoy, Deniz Sahin, Andrea Knapp, Harald Zeuner, Valentin Goede, Alexandra Bazeos, Umberto Vitolo, Laurie H. Sehn, Robert Marcus, Wolfgang Hiddemann, Marek Trněný, Mikkel Z. Oestergaard, Magdalena Klanova
Association between baseline peripheral blood NKCC and tumor NK cell gene expression in FL (A) and DLBCL (B)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1dd681789354e95b95eedb7f0cb0f7c1
https://doi.org/10.1158/1078-0432.22472267.v1
https://doi.org/10.1158/1078-0432.22472267.v1
Autor:
Günter Fingerle-Rowson, Tina Nielsen, Jeffrey M. Venstrom, Christian Klein, Andres Cardona, Christopher R. Bolen, Nathalie Spielewoy, Deniz Sahin, Andrea Knapp, Harald Zeuner, Valentin Goede, Alexandra Bazeos, Umberto Vitolo, Laurie H. Sehn, Robert Marcus, Wolfgang Hiddemann, Marek Trněný, Mikkel Z. Oestergaard, Magdalena Klanova
Purpose:Natural killer (NK) cells are key effector cells for anti-CD20 monoclonal antibodies (mAb), such as obinutuzumab and rituximab. We assessed whether low pretreatment NK-cell count (NKCC) in peripheral blood or tumor tissue was associated with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70b5efac80c8286475bb0868688eb644
https://doi.org/10.1158/1078-0432.c.6528176
https://doi.org/10.1158/1078-0432.c.6528176
Autor:
Paul J. Hengeveld, Michèle Y. van der Klift, P. Martijn Kolijn, Frédéric Davi, François G. Kavelaars, Evert de Jonge, Sandra Robrecht, Jorn L. J. C. Assmann, Lina van der Straten, Matthias Ritgen, Peter E. Westerweel, Kirsten Fischer, Valentin Goede, Michael Hallek, Mark-David Levin, Anton W. Langerak
Publikováno v:
Blood, 141(5), 519-528. American Society of Hematology
The sensitivity of conventional techniques for reliable quantification of minimal/measurable residual disease (MRD) in chronic lymphocytic leukemia (CLL) is limited to MRD 10−4. Measuring MRD −4 could help to further distinguish between patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f5bd5398eaa5ab41346baafa6136627
https://pure.eur.nl/en/publications/c5e32979-91ec-407d-855b-b1641fa666cf
https://pure.eur.nl/en/publications/c5e32979-91ec-407d-855b-b1641fa666cf
Publikováno v:
The Lancet Haematology. 8:e840-e852
Haematological malignancies are a heterogeneous group of diseases with diverse incidence. In Europe, the median age at diagnosis across all disease entities is 69 years. Incidence generally increases with age, reaching a maximum at 75-99 years, with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b6055c1421c9bb7e4b8d713a75c0c48
https://doi.org/10.1016/s2352-3026(21)00241-6
https://doi.org/10.1016/s2352-3026(21)00241-6